Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.
Message: FutTheWuk or others? NEC worth $16M???
Your Vote:
Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Could it be that "Special Losses" of $16M reflect the settlement with TPL/PTSC for NEC Electronics America? Here's the Consolidated Statement of Operations for NEC for 10/1 to 12/31 of 2007. Not an accountant type, so not sure where they would reflect this or even if they would as yet, but hoping someone might be able to decipher or say one way or the other that it is or isn't a possibility.
Three months ended December 31 |
2007 | % of sales |
2006 | % of sales |
Increase (Decrease) |
2007 | ||||||||||||||
Sales |
JPY | 1,052,215 | 100.0 | JPY | 1,096,138 | 100.0 | JPY | (43,923 | ) | $ | 9,395 | |||||||||
Cost of sales |
707,205 | 67.2 | 744,835 | 68.0 | (37,630 | ) | 6,314 | |||||||||||||
Gross profit |
345,010 | 32.8 | 351,303 | 32.0 | (6,293 | ) | 3,080 | |||||||||||||
Selling, general and administrative expenses |
328,997 | 31.3 | 316,268 | 28.8 | 12,729 | 2,937 | ||||||||||||||
Operating income |
16,013 | 1.5 | 35,035 | 3.2 | (19,022 | ) | 143 | |||||||||||||
Non-operating income |
7,386 | 0.7 | 6,918 | 0.6 | 468 | 66 | ||||||||||||||
Interest income |
1,554 | 1,940 | (386 | ) | 14 | |||||||||||||||
Dividend income |
758 | 700 | 58 | 7 | ||||||||||||||||
Equity in earnings of affiliated companies |
1,070 | — | 1,070 | 10 | ||||||||||||||||
Foreign exchange gain |
— | 759 | (759 | ) | — | |||||||||||||||
Others |
4,004 | 3,519 | 485 | 35 | ||||||||||||||||
Non-operating expenses |
13,859 | 1.3 | 19,025 | 1.7 | (5,166 | ) | 124 | |||||||||||||
Interest expense |
3,479 | 4,031 | (552 | ) | 31 | |||||||||||||||
Retirement benefit expenses |
3,454 | 3,479 | (25 | ) | 31 | |||||||||||||||
Loss on disposals of fixed assets |
493 | 737 | (244 | ) | 4 | |||||||||||||||
Foreign exchange loss |
1,311 | — | 1,311 | 12 | ||||||||||||||||
Equity in losses of affiliated companies |
— | 3,065 | (3,065 | ) | — | |||||||||||||||
Others |
5,122 | 7,713 | (2,591 | ) | 46 | |||||||||||||||
Ordinary income |
9,540 | 0.9 | 22,928 | 2.1 | (13,388 | ) | 85 | |||||||||||||
Special gains |
122 | 0.0 | 3,539 | 0.3 | (3,417 | ) | 1 | |||||||||||||
Gain on sales of investment securities |
129 | 2,721 | (2,592 | ) | 1 | |||||||||||||||
Gain on sales of fixed assets |
— | 816 | (816 | ) | — | |||||||||||||||
Gain on change in interests in consolidated subsidiaries and affiliated companies |
(7 | ) | — | (7 | ) | 0 | ||||||||||||||
Gain on lapse of stock subscription rights |
— | 2 | (2 | ) | — | |||||||||||||||
Special losses |
1,845 | 0.2 | 3,346 | 0.3 | (1,501 | ) | 16 | |||||||||||||
Restructuring charges |
1,201 | 2,809 | (1,608 | ) | 11 | |||||||||||||||
Loss on retirement of fixed assets |
576 | — | 576 | 5 | ||||||||||||||||
Loss on devaluation of investment securities |
36 | 530 | (494 | ) | 0 | |||||||||||||||
Impairment loss on fixed assets |
32 | — | 32 | 0 | ||||||||||||||||
Other retirement benefit expenses |
— | 7 | (7 | ) | — | |||||||||||||||
Income before income taxes and minority interests |
7,817 | 0.7 | 23,121 | 2.1 | (15,304 | ) | 70 | |||||||||||||
Provision for income taxes |
16,507 | 1.5 | 20,152 | 1.9 | (3,645 | ) | 147 | |||||||||||||
Minority interests in income (loss) of consolidated subsidiaries |
(3,460 | ) | (0.3 | ) | 354 | 0.0 | (3,814 | ) | (30 | ) | ||||||||||
Net income (loss) |
JPY | (5,230 | ) | (0.5 | ) | JPY | 2,615 | 0.2 | JPY | (7,845 | ) | $ | (47 | ) | ||||||
Loading...
Loading...
New Message
Please
login
to post a reply